How does iqoro work

Overview

Iqoro is a patented medical device developed in Sweden specifically for treating gastroesophageal reflux disease (GERD) and hiatal hernia. The device was invented by Rikard Blomstrand, a Swedish engineer who began developing the concept in 2008 after experiencing GERD symptoms himself. Clinical development involved collaboration with medical professionals at institutions including the Karolinska Institute in Stockholm. The device received CE certification as a Class I medical device in 2015, allowing it to be marketed throughout Europe. Unlike medications that temporarily reduce stomach acid, Iqoro addresses the underlying muscular dysfunction that allows stomach contents to reflux into the esophagus. The device has been used by thousands of patients across Scandinavia and other European countries, with clinical studies showing significant improvement in symptoms for the majority of users without invasive procedures or lifelong medication.

How It Works

Iqoro operates on the principle of neuromuscular training to strengthen the muscles that prevent gastroesophageal reflux. The device consists of a plastic frame with a mouthpiece that users place under their tongue. When the user pulls the device forward with their tongue, it creates negative pressure in the chest cavity, which in turn activates and exercises the upper esophageal sphincter and diaphragm muscles. These muscles form the physiological barrier that normally prevents stomach acid from entering the esophagus. By performing this exercise for 90 seconds, three times daily, users gradually strengthen these muscles over a period of 4-8 weeks. The training improves muscle tone and coordination, helping to restore the natural barrier function. This approach differs fundamentally from medications that merely reduce acid production or surgical interventions that physically alter anatomy.

Why It Matters

Iqoro matters because it offers a non-pharmacological, non-invasive alternative for treating GERD, a condition affecting approximately 20% of the Western population. Traditional treatments often involve lifelong medication with proton pump inhibitors, which can have side effects including nutrient deficiencies and increased fracture risk. Surgical options like fundoplication are invasive and carry significant risks. Iqoro's muscle training approach addresses the root cause of reflux rather than just managing symptoms, potentially providing long-term relief without medication dependence. For patients with hiatal hernia, it offers a conservative treatment option before considering surgery. The device's significance extends to healthcare economics, as effective non-pharmacological treatments could reduce long-term medication costs and surgical interventions for chronic GERD patients.